The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake
@article{Andersson2013TheGA, title={The Grasshopper: A Novel Model for Assessing Vertebrate Brain Uptake}, author={Olga Andersson and Steen Honor{\'e} Hansen and Karin Hellman and Line R{\o}rb{\ae}k Olsen and Gunnar Andersson and Lassina Badolo and Niels Svenstrup and Peter Aadal Nielsen}, journal={The Journal of Pharmacology and Experimental Therapeutics}, year={2013}, volume={346}, pages={211 - 218} }
The aim of the present study was to develop a blood-brain barrier (BBB) permeability model that is applicable in the drug discovery phase. The BBB ensures proper neural function, but it restricts many drugs from entering the brain, and this complicates the development of new drugs against central nervous system diseases. Many in vitro models have been developed to predict BBB permeability, but the permeability characteristics of the human BBB are notoriously complex and hard to predict…
20 Citations
An Insect-Based Ex Vivo Blood Brain Barrier Efflux Assay
- Biology
- 2014
The locust ex-vivo BBB model holds promise as a cheap model with a high-throughput screening potential in the early discovery phase of CNS drugs, which indicates a conserved mechanism of brain efflux activity between insects and vertebrates.
Characterization of a novel brain barrier ex vivo insect-based P-glycoprotein screening model
- BiologyPharmacology research & perspectives
- 2014
It is shown that the locust model has the potential to act as a robust and convenient model for assessing BBB permeability in early drug discovery and to retain the major cues that maintain and modulate the physiological function of the brain barrier.
Development of an a priori computational approach for brain uptake of compounds in an insect model system.
- BiologyBioorganic & medicinal chemistry letters
- 2021
An invertebrate model for CNS drug discovery: Transcriptomic and functional analysis of a mammalian P-glycoprotein ortholog.
- BiologyBiochimica et biophysica acta
- 2015
Barrier mechanisms in the Drosophila blood-brain barrier
- BiologyFront. Neurosci.
- 2014
Findings strengthen the notion that many BBB mechanisms are conserved between vertebrates and invertebrates, and suggest that novel findings in invertebrate model organisms will have a significant impact on the understanding of vertebrate BBB functions.
Molecular determinants of blood-brain barrier permeation.
- BiologyTherapeutic delivery
- 2015
The different computational tools available today, as well as the experimental methods used to determine BBB permeability, are explored, which include in vitro models and the in vivo models that yield the dataset the authors use to generate predictive models.
Identification of a Functional Homolog of the Mammalian CYP3A4 in Locusts
- BiologyDrug Metabolism and Disposition
- 2014
Not only may locusts be a model useful for determining BBB permeation, but possibly insects could be used in metabolism investigation, however, extensive characterization of the insect model is necessary to determine its applicability.
Identification of a Functional Homolog of the Mammalian CYP 3 A 4 in Locusts Line
- Biology
- 2014
Not only may locusts be a model useful for determining BBB permeation, but possibly insects could be used in metabolism investigation, however, extensive characterization of the insect model is necessary to determine its importance.
An ex Vivo Model for Evaluating Blood-Brain Barrier Permeability, Efflux, and Drug Metabolism.
- Biology, PsychologyACS chemical neuroscience
- 2016
Overall, the experiments indicated that invertebrates might be useful for screening of blood-brain barrier permeation, efflux, metabolism, and analysis of the unbound fraction of drugs in the brain in early drug discovery.
Development of a sensitive and quantitative capillary LC-UV method to study the uptake of pharmaceuticals in zebrafish brain
- BiologyAnalytical and Bioanalytical Chemistry
- 2018
Quantitative experiments carried out on pooled samples of six zebrafish demonstrated the selective semipermeable nature of the blood-brain barrier after incubating the zebra fish at the maximum tolerated concentration for the investigated pharmaceuticals.
References
SHOWING 1-10 OF 37 REFERENCES
Novel models for assessing blood–brain barrier drug permeation
- BiologyExpert opinion on drug metabolism & toxicology
- 2012
This focused review covers novel models which have been developed or are in the process of being developed which can be used in modeling BBB and the main model organisms covered here are the grasshopper, fruit fly and zebrafish.
Assays to predict drug permeation across the blood-brain barrier, and distribution to brain.
- Biology, ChemistryCurrent drug metabolism
- 2008
In combination with in silico and in vivo models, the portfolio of methods establishing and predicting CNS drug PK is now very powerful, allowing much more accurate iterative feedback to chemists to optimise compound profiles through the drug discovery and development programme.
Evolutionary Conservation of Vertebrate Blood–Brain Barrier Chemoprotective Mechanisms in Drosophila
- BiologyThe Journal of Neuroscience
- 2009
The Drosophila melanogaster (Dm) humoral/CNS barrier conserves the xenobiotic exclusion properties found in the vertebrate vascular endothelium and this data indicates that the ancient origins of CNS chemoprotection extend to both conserved molecular means and functionally analogous anatomic spaces that together promote CNS selective drug partition.
In vitro models of the blood-brain barrier.
- BiologyActa neurobiologiae experimentalis
- 2011
The in vitro BBB model is characterized by high transendothelial electrical resistance (TEER regularily above 200 Ohm x cm(2), low permeability and expression of several transporters, which has proven that the model is suitable for basic research and for testing the interaction between the BBB and potential drug candidates (toxicity, permeability, interaction with effluxTransporters) as well.
Progress in Brain Penetration Evaluation in Drug Discovery and Development
- BiologyJournal of Pharmacology and Experimental Therapeutics
- 2008
This review discusses strategies to optimize brain penetration from the perspective of drug discovery and development and proposes the following strategies for addressing drug transporters at the blood-brain barrier.
P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.
- BiologyEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- 2009
In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
- BiologyJournal of pharmaceutical sciences
- 2009
This review gives a comprehensive overview of different approaches currently considered in drug discovery to circumvent the lack of small molecule transfer through the BBB, together with their inherent advantages and disadvantages.
Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila
- BiologyGlia
- 2011
It is concluded that many unique BBB physiologies are conserved across phyla and suggest new methods for modeling CNS physiology and disease.